APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)

Aggleton, 1995, A comparison of the effects of medial prefrontal, cingulate cortex, and cingulum bundle lesions on tests of spatial memory: evidence of a double dissociation between frontal and cingulum bundle contributions, J. Neurosci., 15, 7270, 10.1523/JNEUROSCI.15-11-07270.1995 Alexander, G., Hanna, A., Serna, V., Younkin, L., Younkin, S., Janus, C., 2011. Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer's disease. Behav. Brain Res. 216, 77–83. Alexandru, 2011, Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation, J. Neurosci., 31, 12790, 10.1523/JNEUROSCI.1794-11.2011 Ambrée, 2006, Activity changes and marked stereotyped behavior precede Aβ pathology in TgCRND8 Alzheimer mice, Neurobiol. Aging, 27, 955, 10.1016/j.neurobiolaging.2005.05.009 Amieva, 2005, The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, 128, 1093, 10.1093/brain/awh451 Andrä, 1996, Expression of APP in transgenic mice: a comparison of neuron-specific promoters, Neurobiol. Aging, 17, 183, 10.1016/0197-4580(95)02066-7 Arendash, G.W., King, D.L., 2002. Intra- and intertask relationships in a behavioral test battery given to Tg2576 transgenic mice and controls. Physiol. Behav. 75, 643–652. Arendash, 2001, Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes, Brain Res., 891, 42, 10.1016/S0006-8993(00)03186-3 Arendash, G.W., Lewis, J., Leighty, R.E., McGowan, E., Cracchiolo, J.R., Hutton, M., Garcia, M.F., 2004. Multi-metric behavioral comparison of APPsw and P301L models for Alzheimer's disease: linkage of poorer cognitive performance to tau pathology in forebrain. Brain Res. 1012, 29–41. Arsenault, 2011, DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice, PLoS One, 6, e17397, 10.1371/journal.pone.0017397 Ashe, K.H., 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem. 8, 301–308. Ashe, 2010, Probing the biology of Alzheimer's disease in mice, Neuron, 66, 631, 10.1016/j.neuron.2010.04.031 Askanas, V., Engel, W.K., 1998. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr. Opin. Rheumatol. 10, 530–542. Askanas, 2001, Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer's disease, J. Neuropathol. Exp. Neurol., 60, 1, 10.1093/jnen/60.1.1 Askanas, 2002, Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms, Curr. Opin. Neurol., 15, 525, 10.1097/00019052-200210000-00002 Bast, 2001, Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABAA receptor antagonist picrotoxin, Psychopharmacology, 156, 225, 10.1007/s002130100775 Beckmann, 2011, Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Aβ immunotherapy, J. Neurosci., 31, 1023, 10.1523/JNEUROSCI.4936-10.2011 Bellucci, 2006, Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice, Neurobiol. Dis., 23, 260, 10.1016/j.nbd.2006.03.012 Benzing, 1999, Evidence for glial-mediated inflammation in aged APPSW transgenic mice, Neurobiol. Aging, 20, 581, 10.1016/S0197-4580(99)00065-2 Berger-Sweeney, J., McPhie, D.L., Arters, J.A., Greenan, J., Oster-Granite, M.L., Neve, R.L., 1999. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Mol. Brain Res. 66, 150–162. Bertholet, J.Y., Crusio, W.E., 1991. Spatial and non-spatial spontaneous alternation and hippocampal mossy fibre distribution in nine inbred mouse strains. Behav. Brain Res. 43, 197–202. Blanchard, V., Decorte, L., Noguès, X., Micheau, J., 2009. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition. Behav. Brain Res. 201, 147–157. Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., Bayer, T.A., Langui, D., Duyckaerts, C., Tremp, G., Pradier, L., 2003. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp. Neurol. 184, 247–263. Bonardi, C., de Pulford, F., Jennings, D., Pardon, M.-C., 2011. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease. Behav. Brain Res. 222, 89–97. Bondolfi, 2002, Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice, J. Neurosci., 22, 515, 10.1523/JNEUROSCI.22-02-00515.2002 Boon, W.C., van den Buuse, M., Wegener, N., Martin, S., Chua, H.K., Bush, A.I., Masters, C.L., Adlard, P.A., Li, Q.X., 2010. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Aβ-bearing fragment is associated with reduced NMDA receptor density. Behav. Brain Res. 209, 27–35. Borchelt, 1997, Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins, Neuron, 19, 939, 10.1016/S0896-6273(00)80974-5 Borchelt, 1996, Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo, Neuron, 17, 1005, 10.1016/S0896-6273(00)80230-5 Bornemann, K.D., Wiederhold, K-H., Pauli, C., Ermini, F., Stalder, M., Schnell, L., Sommer, B., Jucker, M., Staufenbiel, M., 2001. Aβ-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am. J. Pathol. 158, 63–73. Busche, 2008, Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease, Science, 321, 1686, 10.1126/science.1162844 Calhoun, 1999, Neuron loss in APP transgenic mice, Nature, 395, 755, 10.1038/27351 Calhoun, 1998, Neuronal overexpression of mutant amyloid precursor protein in prominent deposition of cerebrovascular amyloid, Proc. Natl. Acad. Sci. U. S. A., 96, 14088, 10.1073/pnas.96.24.14088 Cao, 1997, Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze, Neuropharmacology, 36, 1089, 10.1016/S0028-3908(97)00094-4 Carroll, 2007, Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice, J. Neurosci., 27, 13357, 10.1523/JNEUROSCI.2718-07.2007 Casas, 2004, Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Aβ42 accumulation in a novel Alzheimer transgenic model, Am. J. Pathol., 165, 1289, 10.1016/S0002-9440(10)63388-3 Chang, 2004, Inhibition of the dopamine system in rat amygdala attenuates the picrotoxin-induced locomotor hyperactivity and hypertension, Clin. Exp. Pharmacol. Physiol., 31, 284, 10.1111/j.1440-1681.2004.03994.x Chapman, 1999, Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice, Nat. Neurosci., 2, 271, 10.1038/6374 Chin, 2005, Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease, J. Neurosci., 25, 9694, 10.1523/JNEUROSCI.2980-05.2005 Chishti, 2001, Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid protein 695, J. Biol. Chem., 276, 21562, 10.1074/jbc.M100710200 Christie, 2001, Structural and functional disruption of vascular smooth cells in a transgenic mouse model of amyloid angiopathy, Am. J. Pathol., 158, 1065, 10.1016/S0002-9440(10)64053-9 Chung, 2000, Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease, Neurol. Clin., 18, 829, 10.1016/S0733-8619(05)70228-0 Clody, 1969, Behavioral effects of lesions of the medial septum of rats, J. Comp. Physiol. Psychol., 67, 344, 10.1037/h0026756 Codita, 2010, Impaired behavior of female tg-ArcSwe APP mice in the IntelliCage. A longitudinal study, Behav. Brain Res., 215, 83, 10.1016/j.bbr.2010.06.034 Cole, J.C., Rodgers, R.J., 1993. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4, 573–580. Cole, G.M., Frautschy, S.A., 1997. Animal models for Alzheimer's disease. Alz. Dis. Rev. 2, 2–10. Collette, 1999, Executive dysfunction in Alzheimer's disease, Cortex, 35, 57, 10.1016/S0010-9452(08)70785-8 Comery, 2005, Acute (-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci., 25, 8898, 10.1523/JNEUROSCI.2693-05.2005 Cotel, M.C., Bayer, T.A., Wirths, O., 2008. Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice. Brain Res. 1222, 207–213. Cotel, 2012, Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice, Neurobiol. Aging, 33, 96, 10.1016/j.neurobiolaging.2010.02.012 Daffner, 1992, Diminished curiosity in patients with probable Alzheimer's disease as measured by exploratory eye movements, Neurology, 42, 320, 10.1212/WNL.42.2.320 Dalvi, 1996, GABAergic influences on plus-maze behaviour in mice, Psychopharmacology, 128, 380, 10.1007/s002130050148 Davis, 2004, Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of β-amyloid precursor, J. Biol. Chem., 279, 20296, 10.1074/jbc.M312946200 Deacon, R.M.J., Koros, E., Bornemann, K.D., Rawlins, J.N., 2009. Aged Tg2576 mice are impaired on social memory and open field habituation tests. Behav. Brain Res. 197, 466–468. Deacon, R.M.J., Cholerton, L.L., Talbot, K., Nair-Roberts, R.G., Sanderson, D.J., Romberg, C., Koros, E., Bornemann, K.D., Rawlins, J.N.P., 2008. Age-dependent and -independent behavioral deficits in Tg2576 mice. Behav. Brain Res. 189, 126–138. Dean, 1981, Age-related differences in behavior across the life span of the C57BL/6J mouse, Exp. Aging Res., 7, 427, 10.1080/03610738108259823 Delatour, B., Gisquet-Verrier, P., 1996. Prelimbic cortex specific lesions disrupt delayed-variable response tasks in the rat. Behav. Neurosci. 110, 1282–1298. Dember, 1958, Spontaneous alternation behavior, Psychol. Bull., 55, 412, 10.1037/h0045446 Dewachter, 2000, Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin on amyloid biochemistry and pathology in APP/London mice, Exp. Gerontol., 35, 831, 10.1016/S0531-5565(00)00149-2 Dewachter, 2000, Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1, Eur. J. Neurosci., 20, 6452, 10.1523/JNEUROSCI.20-17-06452.2000 D’Hooge, 1996, Spatial learning deficit in mice expressing human 751-amino acid β-amyloid precursor protein, NeuroReport, 7, 2807, 10.1097/00001756-199611040-00080 Dineley, 2002, Accelerated plaque accumulation, associative learning deficits, and up-regulation of α7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins, J. Biol. Chem., 277, 22768, 10.1074/jbc.M200164200 Divac, 1975, Spontaneous alternation in rats with lesions in the frontal lobes: an extension of the frontal lobe syndrome, Physiol. Psychol., 3, 29 Dodart, 2002, Does my mouse have Alzheimer's disease?, Genes Brain Behav., 1, 142, 10.1034/j.1601-183X.2002.10302.x Dodart, 1999, Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein, Behav. Neurosci., 113, 982, 10.1037/0735-7044.113.5.982 Domnitz, 2005, Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease, J. Neuropathol. Exp. Neurol., 64, 588, 10.1097/01.jnen.0000171644.00180.fc Duff, K., 1999. Transgenic mouse models of Alzheimer's disease. In: Crusio, W., Gerlai, R. (Eds.), Handbook of Molecular-genetic Techniques for Brain and Behavior Research (Techniques in the Behavioral and Neural Sciences, vol. 13). Elsevier, Amsterdam, pp. 888–894. Duff, 1996, Increased β-amyloid42(43) in brains of mice expressing mutant presenilin 1, Nature, 383, 710, 10.1038/383710a0 Dulawa, 1999, Dopamine D4 receptor-knockout mice exhibit reduced exploration of novel stimuli, J. Neurosci., 19, 9550, 10.1523/JNEUROSCI.19-21-09550.1999 Dumont, 2004, Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation, Brain Res., 1024, 113, 10.1016/j.brainres.2004.07.052 Dumont, 2010, N-iminoethyl-L-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition, Neurochem. Int., 56, 345, 10.1016/j.neuint.2009.11.006 Duyckaerts, 2008, Alzheimer disease models and human neuropathology: similarities and differences, Acta Neuropathol., 115, 5, 10.1007/s00401-007-0312-8 Eikelenboom, 2002, Neuroinflammation in Alzheimer's disease and prion disease, Glia, 40, 232, 10.1002/glia.10146 Eslinger, 1986, Preserved motor learning in Alzheimer's disease: implications for anatomy and behavior, J. Neurosci., 6, 3006, 10.1523/JNEUROSCI.06-10-03006.1986 Faure, 2011, Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease, Neurobiol. Aging, 32, 407, 10.1016/j.neurobiolaging.2009.03.009 Filali, 2009, Age-related cognitive decline and nesting behavior in an APPswe/PS1 bigenic model of Alzheimer's disease, Brain Res., 1292, 93, 10.1016/j.brainres.2009.07.066 Filali, 2011, Anomalies in social behaviors and exploratory activities in an APPswe/PS1 mouse model of Alzheimer's disease, Physiol. Behav., 104, 880, 10.1016/j.physbeh.2011.05.023 File, 1980, The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs, J. Neurosci. Meth., 2, 239, 10.1016/0165-0270(80)90012-6 Frackowiak, 2001, Deposition of Alzheimer's disease vascular amyloid-β is associated with decreased expression of brain L-3-hydroxyacyl-coenzyme A dehydrogenase (ERAB), Brain Res., 907, 44, 10.1016/S0006-8993(01)02497-0 Frisoni, 1999, Behavioral syndromes in Alzheimer's disease: description and correlates, Dement. Geriatr. Cogn. Disord., 10, 130, 10.1159/000017113 Frye, 2008, Effects of progesterone administration and APPswe+PSEN1ΔE9 mutation for cognitive performance of mid-aged mice, Neurobiol. Learn. Mem., 89, 17, 10.1016/j.nlm.2007.09.008 Fryer, 2003, Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice, J. Neurosci., 23, 7889, 10.1523/JNEUROSCI.23-21-07889.2003 Fukumoto, 2010, A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease, J. Neurosci., 30, 11157, 10.1523/JNEUROSCI.2884-10.2010 Fukuchi, 2000, Accumulation of amyloid-β protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor, Int. J. Exp. Pathol., 81, 231, 10.1046/j.1365-2613.2000.00156.x Fukuchi, 1998, Amyloid-β deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy, Am. J. Pathol., 153, 1687, 10.1016/S0002-9440(10)65682-9 Fukuchi, 1993, Selective neurotoxicity of COOH-terminal fragments of the β-amyloid-precursor protein, Neurosci. Lett., 154, 145, 10.1016/0304-3940(93)90192-N Fukuchi, 1996, High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice, Am. J. Pathol., 149, 219 Galvan, 2006, Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664, Proc. Natl. Acad. Sci. U. S. A., 103, 7130, 10.1073/pnas.0509695103 Games, 1995, Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature, 373, 523, 10.1038/373523a0 Gandy, 2010, Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-β oligomers, Ann. Neurol., 68, 220 Garcia-Alloza, 2006, Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease, Neurobiol. Dis., 24, 516, 10.1016/j.nbd.2006.08.017 Gerlai, 2002, Behavioral impairment of APPV717F mice in fear conditioning: is it only cognition?, Behav. Brain Res., 136, 503, 10.1016/S0166-4328(02)00198-5 German, 2004, Mouse models of Alzheimer's disease: insight into treatment, Rev. Neurosci., 15, 353, 10.1515/REVNEURO.2004.15.5.353 Gil-Bea, 2007, Increase of locomotor activity underlying the behavioral dishinbition in Tg2576 mice, Behav. Neurosci., 121, 340, 10.1037/0735-7044.121.2.340 Gimbel, 2010, Memory impairment in transgenic Alzheimer mice requires cellular prion protein, J. Neurosci., 30, 6367, 10.1523/JNEUROSCI.0395-10.2010 Gimenez-Llort, 2007, Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid, Neurosci. Biobehav. Rev., 31, 125, 10.1016/j.neubiorev.2006.07.007 Gonzalez, 2000, Medial prefrontal transection enhances social interaction. I: Behavioral studies, Brain Res., 887, 7, 10.1016/S0006-8993(00)02931-0 Gonzalez-Lima, 2001, Reduced corpus callocum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease, NeuroReport, 12, 2375, 10.1097/00001756-200108080-00018 Gordon, 2002, Time course of the development of Alzheimer-like pathology in the doubly transgenic mice PS1 + APP mouse, Exp. Neurol., 173, 183, 10.1006/exnr.2001.7754 Gorman, 2010, Lifespan daily locomotor activity rhythms in a mouse model of amyloid-induced neuropathology, Chronobiol. Int., 27, 1159, 10.3109/07420528.2010.485711 Görtz, 2008, Effects of environmental enrichment on exploration, anxiety, and memory in female TgCRND8 Alzheimer mice, Behav. Brain Res., 191, 43, 10.1016/j.bbr.2008.03.006 Graham, 2004, Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia, J. Neurol. Neurosurg. Psychiatry, 75, 61 Griebel, 2000, Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice, Psychopharmacology, 148, 164, 10.1007/s002130050038 Gulinello, 2009, Validation of a 2-day water maze protocol in mice, Behav. Brain Res., 196, 220, 10.1016/j.bbr.2008.09.002 Guo, 1999, Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice, Nat. Med., 5, 101, 10.1038/4789 Halagappa, 2007, Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease, Neurobiol. Dis., 26, 212, 10.1016/j.nbd.2006.12.019 Hardy, 1985, Transmitter deficits in Alzheimer's disease, Neurochem. Int., 7, 545, 10.1016/0197-0186(85)90050-6 Harigaya, 2006, Type-specific evolution of amyloid plaque and angiopathy in APPsw mice, Neurosci. Lett., 395, 37, 10.1016/j.neulet.2005.10.087 Harms, 2006, Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging, Exp. Neurol., 199, 408, 10.1016/j.expneurol.2006.01.002 Harrison, 2009, Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice, Pharmacol. Biochem. Behav., 93, 443, 10.1016/j.pbb.2009.06.006 Harrison, 2009, Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice, Nutr. Neurosci., 12, 203, 10.1179/147683009X423364 Hart, 2003, A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease, Int. J. Geriatr. Psychiatry, 18, 1037, 10.1002/gps.1013 Hartmann, 2010, Neurotransmitters and energy metabolites in amyloid-bearing APPSWExPSEN1dE9 mouse brain, J. Pharmacol. Exp. Ther., 332, 364, 10.1124/jpet.109.161091 Hashimoto, 2006, Anxiety and regional cortical glucose metabolism in patients with Alzheimer's disease, J. Neuropsychiatry Clin. Neurosci., 18, 521, 10.1176/appi.neuropsych.18.4.521 Helmes, 2002, Beyond memory impairment: cognitive changes in Alzheimer's disease, Arch. Clin. Neuropsychol., 17, 179, 10.1093/arclin/17.2.179 Henderson, 1989, Spatial disorientation in Alzheimer's disease, Arch. Neurol., 46, 391, 10.1001/archneur.1989.00520400045018 Heneka, 2006, Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice, J. Neurosci., 26, 1343, 10.1523/JNEUROSCI.4236-05.2006 Hirono, 2000, Left frontotemporal hypoperfusion is associated with aggression in patients with dementia, Arch. Neurol., 57, 861, 10.1001/archneur.57.6.861 Hirono, 1998, Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease, J. Neuropsychiat. Clin. Neurosci., 10, 433, 10.1176/jnp.10.4.433 Hock, 2001, Transgenic mouse models of Alzheimer's disease, Trends Genet., 17, S7, 10.1016/S0168-9525(01)02449-0 Holcomb, 1999, Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits, Behav. Genet., 29, 177, 10.1023/A:1021691918517 Holcomb, 1998, Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin transgenes, Nat. Med., 4, 97, 10.1038/nm0198-097 Holmes, 2001, Targeted gene mutation approaches to the study of anxiety-like behavior in mice, Neurosci. Biobehav. Rev., 25, 261, 10.1016/S0149-7634(01)00012-4 Holthoff, 2005, Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression, Biol. Psychiatry, 57, 412, 10.1016/j.biopsych.2004.11.035 Hoojimans, 2009, DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice, Neurobiol. Dis., 33, 482, 10.1016/j.nbd.2008.12.002 Hort, 2007, Spatial navigation deficit in amnestic mild cognitive impairment, Proc. Natl. Acad. Sci. U. S. A., 104, 4042, 10.1073/pnas.0611314104 Howlett, 2009, The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?, Histol. Histopathol., 24, 83 Howlett, 2004, Cognitive correlates of Aβ deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes, Brain Res., 1017, 130, 10.1016/j.brainres.2004.05.029 Hsiao, 1998, Transgenic mice expressing Alzheimer amyloid precursor proteins, Exp. Gerontol., 33, 883, 10.1016/S0531-5565(98)00045-X Hsiao, 1998, Strain dependent and invariant features of transgenic mice expressing Alzheimer amyloid precursor proteins, Prog. Brain Res., 117, 335, 10.1016/S0079-6123(08)64026-1 Hsiao, 1996, Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 Hsiao, 1995, Age-related CNS disorder and early death in transgenic FVB-N mice overexpressing Alzheimer amyloid precursor proteins, Neuron, 15, 1203, 10.1016/0896-6273(95)90107-8 Huang, 2006, Neprilysin-sensitive synapse-associated amyloid-beta peptide oligomers impair neuronal plasticity and cognitive function, J. Biol. Chem., 281, 17941, 10.1074/jbc.M601372200 Huitron-Resendiz, 2002, Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice, Brain Res., 928, 126, 10.1016/S0006-8993(01)03373-X Hyde, 2005, Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice, Behav. Brain Res., 160, 344, 10.1016/j.bbr.2004.12.017 Irizarry, 1997, APPβSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities but no neuronal loss in CA1, J. Neuropathol. Exp. Neurol., 56, 965, 10.1097/00005072-199709000-00002 Iwatsubo, 1994, Visualization of Aβ42(43) and Aβ40 in senile plaques and end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43), Neuron, 13, 45, 10.1016/0896-6273(94)90458-8 Jacobsen, 2006, Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 103, 5161, 10.1073/pnas.0600948103 Jacobs, 1999, Apraxia and motor-skill acquisition in Alzheimer's disease are dissociable, Neuropsychologia, 37, 875, 10.1016/S0028-3932(98)00139-0 Jacobs, 1995, Neuropsychological detection and characterization of preclinical Alzheimer's disease, Neurology, 45, 957, 10.1212/WNL.45.5.957 Jankowsky, 2005, Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease, J. Neurosci., 25, 5217, 10.1523/JNEUROSCI.5080-04.2005 Jankowsky, 2005, Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease, PLoS Med., 2, e355, 10.1371/journal.pmed.0020355 Jankowsky, 2004, Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase, Hum. Mol. Genet., 13, 159, 10.1093/hmg/ddh019 Janus, 2001, Transgenic mouse models of Alzheimer's disease, Physiol. Behav., 73, 873, 10.1016/S0031-9384(01)00524-8 Janus, 2000, Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, Nature, 408, 979, 10.1038/35050110 Jawhar, 2012, Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease, Neurobiol. Aging, 33, 10.1016/j.neurobiolaging.2010.05.027 Jawhar, 2011, Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate Aβ formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice, J. Biol. Chem., 286, 4454, 10.1074/jbc.M110.185819 Jimenez, 2008, Inflammatory response in the hippocampus of PS1M146L/APP751SL mouse model of Alzheimer's disease: age-dependent switch to the microglial phenotype from alternative to classic, J. Neurosci., 28, 11650, 10.1523/JNEUROSCI.3024-08.2008 Johnson, 1977, Damage to hippocampus and hippocampal connections: effects on DRL and spontaneous alternation, J. Comp. Physiol. Psychol., 91, 508, 10.1037/h0077346 Kalback, 2002, APP transgenic mice Tg2576 accumulate Aβ peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques, Biochemistry, 41, 922, 10.1021/bi015685+ Karlsson, 2002, Successive memory test performance and priming in Alzheimer's disease: evidence from the word-fragment completion task, Cortex, 38, 341, 10.1016/S0010-9452(08)70664-6 Kavcic, 2006, Neurophysiological and perceptual correlates of navigational impairment in Alzheimer's disease, Brain, 129, 736, 10.1093/brain/awh727 Kawarabayashi, 2001, Age-dependent changes in brain, CSF, and amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease, J. Neurosci., 21, 372, 10.1523/JNEUROSCI.21-02-00372.2001 Kawarabayashi, 2004, Dimeric amyloid β protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci., 24, 3801, 10.1523/JNEUROSCI.5543-03.2004 Kessels, 2005, Implicit and explicit memory for spatial information in Alzheimer's disease, Dement. Geriatr. Cogn. Disord., 20, 184, 10.1159/000087233 Kim, 1996, Neurotoxicity of a carboxyl-terminal fragment of the Alzheimer's amyloid precursor protein, J. Neurochem., 67, 1172, 10.1046/j.1471-4159.1996.67031172.x Kimchi, 2001, Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer's disease using in vivo multiphoton microscopy, J. Neuropathol. Exp. Neurol., 60, 274, 10.1093/jnen/60.3.274 King, 2002, Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months, Physiol. Behav., 75, 627, 10.1016/S0031-9384(02)00639-X Kirkby, 1967, Effects of hippocampal lesions and duration of sensory input on spontaneous alternation, J. Comp. Physiol. Psychol., 64, 342, 10.1037/h0088012 Kitamoto, 2002, Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions, Biochem. Biophys. Res. Commun., 294, 280, 10.1016/S0006-291X(02)00476-X Kitazawa, 2006, Genetically augmenting Aβ42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice, Am. J. Pathol., 168, 1986, 10.2353/ajpath.2006.051232 Köhler, 1980, Effects of lateral and medial septal lesions on exploratory behavior in the albino rat, Brain Res., 182, 423, 10.1016/0006-8993(80)91199-3 Kokjohn, 2009, Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions, Alzheimers Dement., 5, 340, 10.1016/j.jalz.2009.03.002 Kumar-Singh, 2000, Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation, Neurobiol. Dis., 7, 9, 10.1006/nbdi.1999.0272 Kuo, 2001, Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains, J. Biol. Chem., 276, 12991, 10.1074/jbc.M007859200 Kuo, 2001, The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease, Mol. Med., 7, 609, 10.1007/BF03401867 Kurt, 2003, Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes, Neurobiol. Dis., 14, 89, 10.1016/S0969-9961(03)00084-6 LaFerla, 1996, Extracellular deposition of β-amyloid upon p53-dependent neuronal cell death in transgenic mice, J. Clin. Invest., 98, 1626, 10.1172/JCI118957 LaFerla, 1995, The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice, Nat. Genet., 9, 21, 10.1038/ng0195-21 Lalonde, 2002, The neurobiological basis of spontaneous alternation, Neurosci. Biobehav. Rev., 26, 91, 10.1016/S0149-7634(01)00041-0 Lalonde, 2010, Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents, Fundam. Clin. Pharmacol., 24, 365, 10.1111/j.1472-8206.2009.00772.x Lalonde, 2004, Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/ΔE9 mice, Neurosci. Lett., 369, 156, 10.1016/j.neulet.2004.07.069 Lalonde, 2005, Exploratory activity and spatial learning in 12-month-old APP695SWE/co+PS1/ΔE9 mice with amyloid plaques, Neurosci. Lett., 390, 87, 10.1016/j.neulet.2005.08.028 Lalonde, 2002, Transgenic mice expressing the human C99 terminal fragment of βAPP: effects on spatial learning, exploration, anxiety, and motor coordination, Exp. Gerontol., 37, 1399, 10.1016/S0531-5565(02)00123-7 Lalonde, 2002, Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation, Brain Res., 956, 36, 10.1016/S0006-8993(02)03476-5 Lalonde, 2003, Neurobehavioral testing of transgenic βAPP695SWE (Tg2576) mice with the Swedish mutation, Brain Res., 977, 38, 10.1016/S0006-8993(03)02694-5 Lamberty, 1990, Age-related changes in spontaneous behavior and learning in NMRI mice from maturity to middle age, Physiol. Behav., 47, 1137, 10.1016/0031-9384(90)90364-A Lamberty, 1992, Age-related changes in spontaneous behavior and learning in NMRI mice from middle to old age, Physiol. Behav., 51, 81, 10.1016/0031-9384(92)90206-H Lanari, 2006, Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease, Mech. Ageing Dev., 127, 158, 10.1016/j.mad.2005.09.016 Lanz, 2003, Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype, Neurobiol. Dis., 13, 246, 10.1016/S0969-9961(03)00079-2 Lassalle, 2008, Effects of the genetic background on cognitive performances of TG2576 mice, Behav. Brain Res., 191, 104, 10.1016/j.bbr.2008.03.017 Le Cudennec, 2008, One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice, Genes Brain Behav., 7, 83, 10.1111/j.1601-183X.2007.00374.x Lee, 2003, Associative and recognition memory for novel objects in dementia: implications for diagnosis, Eur. J. Neurosci., 18, 1660, 10.1046/j.1460-9568.2003.02883.x Lee, 2005, Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease, Brain Res. Bull., 65, 317, 10.1016/j.brainresbull.2004.11.024 Lee, 2004, Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein, J. Neurosci. Res., 76, 572, 10.1002/jnr.20127 Lee, 2006, Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein, Neurobiol. Dis., 22, 10, 10.1016/j.nbd.2005.09.011 Levy, 2006, Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits, Cereb. Cortex, 16, 916, 10.1093/cercor/bhj043 Lewejohann, 2009, Behavioral phenotyping of a murine model of Alzheimer's disease in a seminaturalistic environment using RFID tracking, Behav. Res. Methods, 41, 850, 10.3758/BRM.41.3.850 Li, 1999, Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice, J. Neurochem., 72, 2479, 10.1046/j.1471-4159.1999.0722479.x Lim, 2001, Ibuprofen effects on Alzheimer pathology and open field activity in APPSW transgenic mice, Neurobiol. Aging, 22, 983, 10.1016/S0197-4580(01)00299-8 Liu, 2002, The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice, Exp. Neurol., 173, 196, 10.1006/exnr.2001.7819 Liu, 2008, Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease, J. Neurosci., 28, 13805, 10.1523/JNEUROSCI.4218-08.2008 Lord, 2006, The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice, Neurobiol. Aging, 27, 67, 10.1016/j.neurobiolaging.2004.12.007 Lord, 2009, Amyloid-β protofibril levels correlate with spatial learning in Arctic Alzheimer's disease transgenic mice, FEBS J., 276, 995, 10.1111/j.1742-4658.2008.06836.x Lüth, 2002, Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation, Brain Res., 953, 135, 10.1016/S0006-8993(02)03280-8 Lüth, 2001, Expression of endothelial and induced NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology, Brain Res., 913, 57, 10.1016/S0006-8993(01)02758-5 Lyketsos, 2002, Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study, JAMA, 288, 1475, 10.1001/jama.288.12.1475 Lyness, 2003, Neuron loss in key cholinergic and aminergic nuclei in Alzheimer's disease: a meta-analysis, Neurobiol. Aging, 24, 1, 10.1016/S0197-4580(02)00057-X Marshall, 2007, Positron emission tomography metabolic correlates of apathy in Alzheimer disease, Arch. Neurol., 64, 1015, 10.1001/archneur.64.7.1015 Marutle, 2002, Elevated levels of Aβ1-40 and Aβ1-42 do not alter the binding sites of nicotinic recepeptor subtypes in the brain of APPswe and PS1 double transgenic mice, Neurosci. Lett., 328, 269, 10.1016/S0304-3940(02)00546-3 Masliah, 2001, Neurofibrillary pathology in transgenic mice overexpressing V717F β-amyloid precursor protein, J. Neuropathol. Exp. Neurol., 60, 357, 10.1093/jnen/60.4.357 Masliah, 1996, Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease, J. Neurosci., 16, 5795, 10.1523/JNEUROSCI.16-18-05795.1996 Massaad, 2009, Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 106, 13576, 10.1073/pnas.0902714106 McGowan, 2006, A decade of modeling Alzheimer's disease in transgenic mice, Trends Genet., 22, 281, 10.1016/j.tig.2006.03.007 McGowan, 2005, Aβ42 is essential for parenchymal and vascular amyloid deposition in mice, Neuron, 47, 191, 10.1016/j.neuron.2005.06.030 McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA work group under the Department of Health and Human Services task force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 McLellan, 2003, In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy, J. Neurosci., 23, 2212, 10.1523/JNEUROSCI.23-06-02212.2003 McPhie, 1997, Neuronal expression of β-amyloid-precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid β and cytoplasmic domains, J. Biol. Chem., 272, 24743, 10.1074/jbc.272.40.24743 Menard, 1998, The septum and the hippocampus differentially mediate anxiolytic effects of R(+)-8-OH-DPAT, Behav. Pharmacol., 9, 93 Menard, 2001, The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal L-glutamate, Brain Res., 888, 163, 10.1016/S0006-8993(00)03046-8 Mentis, 1995, Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease, Biol. Psychiat., 38, 438, 10.1016/0006-3223(94)00326-X Middei, 2004, Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe, Learn. Mem., 11, 447, 10.1101/lm.80604 Middei, 2006, Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe, Genes Brain Behav., 5, 249, 10.1111/j.1601-183X.2005.00160.x Mineur, 2005, Genetic models of Alzheimer's disease, Neural Plast., 12, 299, 10.1155/NP.2005.299 Moechars, 1999, Premature death in transgenic mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apoptosis, Neuroscience, 91, 819, 10.1016/S0306-4522(98)00599-5 Moechars, 1998, Transgenic mice expressing an alpha-secretion mutant of the amyloid precursor protein in the brain develop a progressive CNS disorder, Behav. Brain Res., 95, 55, 10.1016/S0166-4328(97)00210-6 Moechars, 1996, Expression in brain of amyloid precursor protein mutated in the α-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice, EMBO J., 15, 1265, 10.1002/j.1460-2075.1996.tb00468.x Moechars, 1999, Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain, J. Biol. Chem., 274, 6483, 10.1074/jbc.274.10.6483 Monacelli, 2003, Spatial disorientation in Alzheimer's disease: the remembrance of things passed, Neurology, 61, 1491, 10.1212/WNL.61.11.1491 Moran, 1995, Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid protein precursor protein, Proc. Natl. Acad. Sci. U. S. A., 92, 5341, 10.1073/pnas.92.12.5341 Moreira, 2007, Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei, Brain Res. Bull., 71, 466, 10.1016/j.brainresbull.2006.10.004 Morgan, 2003, Learning and memory deficits in APP transgenic mouse models of amyloid deposition, Neurochem. Res., 28, 1029, 10.1023/A:1023255106106 Morgenstern, 1984, Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens, Pharmacol. Biochem. Behav., 21, 501, 10.1016/S0091-3057(84)80030-1 Mucke, 1994, Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice, Brain Res., 666, 151, 10.1016/0006-8993(94)90767-6 Mucke, 2000, High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci., 20, 4050, 10.1523/JNEUROSCI.20-11-04050.2000 Mueggler, 2003, Age-dependent impairment of somatosensory response in the amyloid precursor protein 23 transgenic mouse model of Alzheimer's disease, J. Neurosci., 23, 8231, 10.1523/JNEUROSCI.23-23-08231.2003 Mueggler, 2004, Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis, Eur. J. Neurosci., 20, 811, 10.1111/j.1460-9568.2004.03534.x Mueggler, 2002, Compromised hemodynamic response in amyloid precursor transgenic mice, J. Neurosci., 22, 7218, 10.1523/JNEUROSCI.22-16-07218.2002 Murray, 1986, Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis, Behav. Neurosci., 100, 23, 10.1037/0735-7044.100.1.23 Müller, 1994, Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor protein gene, Cell, 79, 755, 10.1016/0092-8674(94)90066-3 Nalbantoglu, 1997, Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein, Nature, 387, 500, 10.1038/387500a0 Nelson, 2007, Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice, Exp. Neurol., 205, 166, 10.1016/j.expneurol.2007.01.037 Nic Dhonnchadha, 2003, Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety, Behav. Brain Res., 140, 203, 10.1016/S0166-4328(02)00311-X Nielson, 1996, Constructional apraxia in Alzheimer's disease correlates with neuritic neuropathology in occipital cortex, Brain Res., 741, 284, 10.1016/S0006-8993(96)00983-3 Nunes-de-Souza, 2000, Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam, Psychopharmacology, 150, 300, 10.1007/s002130000428 Oakley, 2006, Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J. Neurosci., 26, 10129, 10.1523/JNEUROSCI.1202-06.2006 Obulesu, 2010, Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues, Int. J. Neurosci., 120, 531, 10.3109/00207451003760080 Oddo, 2003, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction, Neuron, 39, 409, 10.1016/S0896-6273(03)00434-3 Ognibene, 2005, Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease, Behav. Brain Res., 156, 225, 10.1016/j.bbr.2004.05.028 Ohno, 2004, BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease, Neuron, 41, 27, 10.1016/S0896-6273(03)00810-9 Ojha, 2011, Behavioral defects in chaperone-deficient Alzheimer's disease model mice, PLoS One, 6, e16550, 10.1371/journal.pone.0016550 Oster-Granite, 1996, Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein, J. Neurosci., 16, 6732, 10.1523/JNEUROSCI.16-21-06732.1996 Palop, 2003, Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits, Proc. Natl. Acad. Sci. U. S. A., 100, 9572, 10.1073/pnas.1133381100 Parasuraman, 2000, Alzheimer disease constricts the dynamic range of spatial attention in visual search, Neuropsychologia, 38, 1126, 10.1016/S0028-3932(00)00024-5 Pardon, 2009, Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels, Neurobiol. Aging, 30, 1099, 10.1016/j.neurobiolaging.2007.10.002 Perez, 2005, Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1ΔE9 transgenic mice, J. Neurosci., 25, 10220, 10.1523/JNEUROSCI.2773-05.2005 Petry, 1988, Personality alterations in dementia of the Alzheimer type, Arch. Neurol., 45, 1187, 10.1001/archneur.1988.00520350025009 Pietropaolo, 2008, Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer's disease, Behav. Neurosci., 122, 733, 10.1037/a0012520 Pietropaolo, 2009, Limited impact of social isolation on Alzheimer-like symptoms in a triple transgenic model, Behav. Neurosci., 123, 181, 10.1037/a0013607 Pugh, 2007, Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease, Behav. Brain Res., 178, 18, 10.1016/j.bbr.2006.11.044 Puoliväli, 2002, Hippocampal Aβ42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice, Neurobiol. Dis., 9, 339, 10.1006/nbdi.2002.0481 Qian, 1998, Mutant human presenilin-1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 production, Neuron, 20, 611, 10.1016/S0896-6273(00)80999-X Qin, 2000, Patho-morphological and immunohistochemical findings in brains of APP transgenic model, Acta Lab. Sci. Sinica, 8, 213 Quinn, 2003, Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease, J. Neuroimmunol., 137, 32, 10.1016/S0165-5728(03)00037-7 Quon, 1991, Formation of β-amyloid protein deposits in brains of transgenic mice, Nature, 352, 239, 10.1038/352239a0 Radde, 2006, Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology, EMBO Rep., 7, 940, 10.1038/sj.embor.7400784 Rainville, 2002, Performances of patients with a dementia of the Alzheimer type in the Standardized Road-Map test of Direction Sense, Neuropsychologia, 40, 567, 10.1016/S0028-3932(01)00133-6 Rainville, 2002, Executive function deficits in patients with dementia of the Alzheimer's type: a study with a Tower of London task, Arch. Clin. Neuropsychol., 17, 513, 10.1093/arclin/17.6.513 Redwine, 2003, Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis, Proc. Natl. Acad. Sci. U. S. A., 100, 1381, 10.1073/pnas.242746599 Reilly, 2003, Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model, Proc. Natl. Acad. Sci. U. S. A., 100, 4837, 10.1073/pnas.0330745100 Reiserer, 2007, Impaired spatial learning in the APPSwe+PSEN1deltaE9 bigenic mouse model of Alzheimer's disease, Genes Brain Behav., 6, 54, 10.1111/j.1601-183X.2006.00221.x Richards, 2003, PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation, J. Neurosci., 23, 8989, 10.1523/JNEUROSCI.23-26-08989.2003 Richardson, 2003, Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease, Neuroscience, 122, 213, 10.1016/S0306-4522(03)00389-0 Richner, 2009, Over expression of amyloid beta-protein reduces the number of neurons in the striatum of APPswe/PS1/ΔE9, Brain Res., 1266, 87, 10.1016/j.brainres.2009.02.025 Roberts, 1962, Alternation and exploration in rats with hippocampal lesions, J. Comp. Physiol. Psychol., 55, 695, 10.1037/h0045168 Rodgers, 2002, Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline, Genes Brain Behav., 1, 242, 10.1034/j.1601-183X.2002.10406.x Rodrigo, 2004, Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice, Neuroscience, 128, 73, 10.1016/j.neuroscience.2004.06.030 Sadowski, 2004, Amyloid-β deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice, J. Neuropathol. Exp. Neurol., 63, 418, 10.1093/jnen/63.5.418 Sant’Angelo, 2003, Usefulness of behavioral and electrophysiological studies in transgenic models of Alzheimer disease, Neurochem. Res., 28, 1009, 10.1023/A:1023251005197 Savonenko, 2003, Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpresing APPSWE, Neurobiol. Dis., 12, 194, 10.1016/S0969-9961(02)00012-8 Savonenko, 2005, Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to β-amyloid deposition and neurotransmitter abnormalities, Neurobiol. Dis., 18, 602, 10.1016/j.nbd.2004.10.022 Scearce-Levie, K., 2011. Monitoring spatial learning and memory in Alzheimer's disease mouse models using the Morris water maze. In: Roberson, E.D. (Ed.) Alzheimer's Disease and Frontotemporal Dementia (Methods Mol Biol 670), Berlin, Springer, pp. 191–205. Schenk, 1997, The PDAPP transgenic mouse as an animal model for Aβ-induced amyloidosis and neuropathology, Alzheimer Dis. Rev., 2, 20 Schmalzigaug, 2009, Anxiety-like behaviors in mice lacking GIT2, Neurosci. Lett., 452, 156, 10.1016/j.neulet.2008.12.034 Schmitz, 2004, Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease, Am. J. Pathol., 164, 1495, 10.1016/S0002-9440(10)63235-X Scholtzova, 2009, Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology, J. Neurosci., 29, 1846, 10.1523/JNEUROSCI.5715-08.2009 Seabrook, 1999, Transgenic animals relevant to Alzheimer's disease, Neuropharmacology, 8, 1, 10.1016/S0028-3908(98)00170-1 Senanarong, 2004, Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction, Dement. Geriatr. Cogn. Disord., 17, 14, 10.1159/000074080 Senechal, 2008, Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA, Brain Res., 1243, 124, 10.1016/j.brainres.2008.09.024 Shie, 2003, Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice, NeuroReport, 14, 123, 10.1097/00001756-200301200-00023 Smith, 1998, Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neurendocrine development, Neuron, 20, 1093, 10.1016/S0896-6273(00)80491-2 Spires, 2005, Transgenic models of Alzheimer's disease: learning from animals, NeuroRx, 2, 423, 10.1602/neurorx.2.3.423 Sprott, 1974, Open-field behavior in aging inbred mice, Gerontologia, 20, 155, 10.1159/000212009 Stalder, 1999, Association of microglia with amyloid plaques in brains of APP23 transgenic mice, Am. J. Pathol., 154, 1673, 10.1016/S0002-9440(10)65423-5 Stein, 2002, Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways, J. Neurosci., 22, 7380, 10.1523/JNEUROSCI.22-17-07380.2002 Stein, 2003, Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity, Rev. Neurosci., 14, 317, 10.1515/REVNEURO.2003.14.4.317 Stevens, 1973, Effects of dorsal and ventral hippocampal lesions on spontaneous alternation, learned alternation and probability learning in rats, Brain Res., 52, 203, 10.1016/0006-8993(73)90659-8 Storey, 1999, The amyloid precursor protein of Alzheimer's disease and the Aβ peptide, Neuropathol. Appl. Neurobiol., 25, 81, 10.1046/j.1365-2990.1999.00164.x Sturchler-Pierrat, 1997, Two precursor protein transgenic mouse models with Alzheimer disease-like pathology, Proc. Natl. Acad. Sci. U. S. A., 94, 13287, 10.1073/pnas.94.24.13287 Sugarman, 2002, Inclusion body myositis-like phenotype induced by transgenic overexpression of βAPP in skeletal muscle, Proc. Natl. Acad. Sci. U. S. A., 99, 6334, 10.1073/pnas.082545599 Sykova, 2005, Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease, Proc. Natl. Acad. Sci. U. S. A., 102, 479, 10.1073/pnas.0408235102 Szot, 2009, Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice, Neurosci. Lett., 463, 93, 10.1016/j.neulet.2009.07.055 Tabuchi, 2009, Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease, J. Ethnopharmacol., 122, 157, 10.1016/j.jep.2008.12.010 Takahashi, 2002, Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology, Am. J. Pathol., 161, 1869, 10.1016/S0002-9440(10)64463-X Tales, 2004, The effects of saliency and task difficulty on visual search performance in ageing and Alzheimer's disease, Neuropsychologia, 42, 335, 10.1016/j.neuropsychologia.2003.08.002 Tecott, 1998, Perturbed dentate gyrus function in 5-HT2c receptor mutant mice, Proc. Natl. Acad. Sci. U. S. A., 95, 15026, 10.1073/pnas.95.25.15026 Terai, 2001, β-Amyloid deposits in transgenic mice expressing human βamyloid precursor protein have the same characteristics as those in Alzheimer's disease, Neuroscience, 104, 299, 10.1016/S0306-4522(01)00095-1 Tetewsky, 1999, Visual loss and getting lost in Alzheimer's disease, Neurology, 52, 958, 10.1212/WNL.52.5.958 Thal, 2000, Sequence of Aβ-protein deposition in the human medial temporal lobe, J. Neuropathol. Exp. Neurol., 59, 733, 10.1093/jnen/59.8.733 Timmer, 2010, Enoxaparin treatment administered at both early and late stages of Aβ deposition improves cognition of APPswe/PS1dE9 mice with differential effects on brain Aβ levels, Neurobiol. Dis., 40, 340, 10.1016/j.nbd.2010.06.008 Tiraboschi, 2004, The importance of neuritic plaques and tangles to the development and evolution of AD, Neurology, 62, 1984, 10.1212/01.WNL.0000129697.01779.0A Tiraboschi, 2004, Alzheimer disease without neocortical neurofibrillary tangles: “a second look”, Neurology, 62, 1141, 10.1212/01.WNL.0000118212.41542.E7 Tomidokoro, 2001, Brain Aβ amyloidosis in APPSW mice induces accumulation of presenilin-1 and tau, J. Pathol., 193, 500, 10.1002/path.897 Touma, 2004, Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease, Neurobiol. Aging, 25, 893, 10.1016/j.neurobiolaging.2003.09.004 Treit, 1997, Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions, Behav. Neurosci., 111, 653, 10.1037/0735-7044.111.3.653 Tremml, 1998, Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified β-amyloid-precursor protein gene, Behav. Brain Res., 95, 65, 10.1016/S0166-4328(97)00211-8 Turner, 2003, Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory, Prog. Neurobiol., 70, 1, 10.1016/S0301-0082(03)00089-3 Uc, 2004, Driver route-following and safety errors in early Alzheimer disease, Neurology, 63, 832, 10.1212/01.WNL.0000139301.01177.35 Ueki, 2006, Prepulse inhibition of acoustic startle response in mild cognitive impairment and mild dementia of Alzheimer type, Psychiatry Clin. Neurosci., 60, 55, 10.1111/j.1440-1819.2006.01460.x Van Dam, 2003, Age-dependent cognitive decline in the APP23 model precedes amyloid deposition, Eur. J. Neurosci., 17, 388, 10.1046/j.1460-9568.2003.02444.x Van Dam, 2005, APP23 Mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder, CNS Spectr., 10, 207, 10.1017/S1092852900010051 Van Dorpe, 2000, Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons, Am. J. Pathol., 157, 1283, 10.1016/S0002-9440(10)64644-5 van Leuven, 2000, Single and multiple transgenic mice as models for Alzheimer's disease, Prog. Neurobiol., 61, 305, 10.1016/S0301-0082(99)00055-6 Vloeberghs, 2007, Mood and male sexual behaviour in the APP23 model of Alzheimer's disease, Behav. Brain Res., 180, 146, 10.1016/j.bbr.2007.03.002 Vloeberghs, 2004, Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances, Eur. J. Neurosci., 20, 2757, 10.1111/j.1460-9568.2004.03755.x Walker, 2011, Spatial learning and memory impairment and increased locomotion in a transgenic amyloid precursor protein mouse model of Alzheimer's disease, Behav. Brain Res., 222, 169, 10.1016/j.bbr.2011.03.049 Walsh, 1976, The open-field test: a critical review, Psychol. Bull., 83, 482, 10.1037/0033-2909.83.3.482 Wang, 2003, Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice, Neurobiol. Dis., 14, 318, 10.1016/j.nbd.2003.08.009 Wegiel, 2003, Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice, Acta Neuropathol., 105, 392, 10.1007/s00401-002-0660-3 Wegiel, 2001, The role of microglial cells and astrocytes in fibrillar plaque evolution in transgene APPSW mice, Neurobiol. Aging, 22, 49, 10.1016/S0197-4580(00)00181-0 Weintraub, S., Mesulam, M.M., 1993. Four neuropsychological profiles in dementia. In: Spinnler, H., Boller, F. (Eds.) Handbook of Neuropsychology, vol. 8, Elsevier, Amsterdam, pp. 253–282. Weiss, 2002, Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice, Neurobiol. Dis., 11, 425, 10.1006/nbdi.2002.0555 Westerman, 2002, The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease, J. Neurosci., 22, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 Whitford, 1986, Alzheimer's disease and serotonin: a review, Neuropsychobiology, 15, 133, 10.1159/000118256 Winkler, 2001, Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy, J. Neurosci., 21, 1619, 10.1523/JNEUROSCI.21-05-01619.2001 Wirths, 2010, Neuron loss in transgenic mouse models of Alzheimer's disease, Int. J. Alzheimers Dis., 10.4061/2010/723782 Wirths, 2008, Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease, Neurobiol. Aging, 29, 891, 10.1016/j.neurobiolaging.2006.12.004 Woodruff-Pak, 1996, Alzheimer's disease and eyeblink conditioning: 750 ms trace vs. 400 ms delay paradigm, Neurobiol. Aging, 17, 397, 10.1016/0197-4580(96)00022-X Woodruff-Pak, 1996, Training to criterion in eyeblink classical conditioning in Alzheimer's disease. Down's syndrome with Alzheimer's disease, and healthy elderly, Behav. Neurosci., 110, 22, 10.1037/0735-7044.110.1.22 Wu, 2004, Selective vulnerability of dentate granule cells prior to amyloid deposition in PDAPP mice: digital morphometric analyses, Proc. Natl. Acad. Sci. U. S. A., 101, 7141, 10.1073/pnas.0402147101 Yamaguchi, 1991, Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory, NeuroReport, 2, 781, 10.1097/00001756-199112000-00013